Tiziana Life Sciences (TLSA) - 2021 Q2 - Quarterly Report

Report of Foreign Private Issuer (Form 6-K) Filing Information This section details the filing specifics of Form 6-K by Tiziana Life Sciences plc, a foreign private issuer, on June 30, 2021 - Company: Tiziana Life Sciences plc[1] - Filing Date: June 30, 2021[9] - Report Type: Form 6-K, Report of Foreign Private Issuer[1] Information Contained in this Report on Form 6-K This section outlines key information in the Form 6-K, including a UK RNS announcement on an interview and AGM results - On June 30, 2021, the company issued a regulatory news service (RNS) announcement in the United Kingdom[4] - The announcement covers an interview with Dr Howard Weiner on Bloomberg Markets and the Annual General Meeting results[4] - The RNS Announcement is furnished as Exhibit 99.1 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934[5] Exhibit Index This section lists the exhibit included with the Form 6-K filing List of Exhibits | Exhibit No. | Description | | :--- | :--- | | 99.1 | Regulatory News Service Announcement, dated June 30, 2021 |